WHO ICTRP trial
Impact of AI-Based Diagnostics on Patient* Acceptance: An Investigation in the…
DRKS00035010 · German Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | DRKS00035010 |
|---|---|
| Public title | Impact of AI-Based Diagnostics on Patient* Acceptance: An Investigation in the Context of Breast Cancer Screening |
| Scientific title | Impact of AI-Based Diagnostics on Patient* Acceptance: An Investigation in the Context of Breast Cancer Screening - AI Second Opinion |
| Primary sponsor | Fraunhofer-Institut für Digitale Medizin MEVIS |
| Registry | German Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Countries | Germany |
| Conditions | C50;Malignant neoplasm of breast |
| Interventions | Group 1: First opinion: Physican Second opinion: AI Diagnoses are consistent Group 2: First opinion: Physican Second opinion: AI Diagnoses are not consistent Group 3: First opinion: AI Second opinion: Physican Diagnoses are consistent Group… |
| Registration date | Apr 9, 2024 |
| Target size | 350 |
| Registry page | drks.de |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: